I do wonder if this would change if m2m shows positive results though. As Dr. Jay said at the beginning, these other companies are sucking the oxygen out of the room. If we show great results in m2m and the s/c safety peek doesn't result in halting the trial, I would like to believe the publicity of our success could help enroll that trial a lot quicker as doctors become more aware of it and patients ask to get on the trial.